Anne Wojcicki, co-founder and CEO of 23andMe, is considering a go-private transaction for the DNA-testing company after a significant drop in its market value, with its stock price now at 36 cents. The company, which went public three years ago, has seen its valuation plummet from a peak of $6 billion. This move comes as the company's shares have recently surged by 36.1% following the announcement. Wojcicki, who already holds more than 20% of the company's outstanding stock and 49.9% of its voting stock, is likely to need to raise capital to finance the buyout.